Tuesday, December 10, 2019

Panacea Biotec launches generic diabetes treatment drug in India

Panacea Biotec launches generic diabetes treatment drug in India The four formulations are Vildagliptin 50 mg, Vildagliptin 50 mg Metformin HCL 500 mg, Vildagliptin 50 mg Metformin HCL 850 mg and Vildagliptin 50 mg Metformin HCL 1,000 mg, Panacea Biotec said in a filing to the BSE.

from Moneycontrol Business News https://ift.tt/2E1mLy1
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Will proposed US tariffs trigger further Indian market decline? Experts weigh in

Indian stock markets experienced a significant drop on Thursday, with major indices falling around 1 percent. This decline, the steepest sin...